
Iprag M 1500mcg/150mg Tablet SR
Marketer
Iva Healthcare Pvt. Ltd.
Salt Composition
Methylcobalamin (1500mcg) + Pregabalin (150mg)
Overview Iprag M 1500mcg/150mg Tablet SR
Gabapentinoid SR 1500mcg/150mg tablets are prescribed to manage neuropathic pain. They work by altering calcium channel function within nerve cells, thus reducing pain signals. This medication also offers neuroprotective benefits, aiding in nerve fiber preservation and the repair of damaged neurons. Gabapentinoid SR tablets are taken orally, with or without food, ideally at bedtime for consistent plasma levels. Maintain a regular dosing schedule as prescribed; this medication can be habit-forming. If a dose is missed, take it immediately upon recollection. Complete the entire course of treatment, even if symptoms improve. Abrupt cessation should only occur under medical supervision. Common side effects include upper respiratory infection, increased hunger, elevated mood, trembling, visual blurring, dry mouth, lightheadedness, and drowsiness. Avoid tasks requiring alertness until the medication's effects are known. Side effects are usually mild and resolve over time. Weight gain is possible; regular exercise and a balanced diet can help mitigate this. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your physician. Always disclose all other medications being taken, as interactions can influence this medication's efficacy or mechanism. Disclose pregnancy, pregnancy plans, or breastfeeding to your doctor.
Uses of Iprag M 1500mcg/150mg Tablet SR
Managing neuropathic pain
Major Benefits of Iprag M 1500mcg/150mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Iprag M 1500mcg/150mg Tablet SR whole; avoid chewing, crushing, or breaking it. Consistency is key; while this extended-release tablet can be taken with or without food, a regular schedule is recommended.
Common Side effects of Iprag M 1500mcg/150mg Tablet SR:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Iprag M 1500mcg/150mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Iprag M 1500mcg/150mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consumption may coincide with meals or be taken independently, however, consistent timing is recommended for optimal results.
How Iprag M 1500mcg/150mg Tablet SR works:
Iprag M tablets (1500mcg/150mg sustained-release) combine methylcobalamin and pregabalin to manage neuropathic pain. Methylcobalamin, a vitamin B12 derivative, supports myelin sheath formation and repair, protecting nerve fibers. Pregabalin, acting as an alpha-2-delta ligand, reduces pain signals by modulating nerve cell calcium channels. This dual action provides effective relief from nerve damage-related pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Iprag M 1500mcg/150mg sustained-release tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Iprag M 1500mcg/150mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Iprag M tablets (1500mcg/150mg) are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Extended-release Iprag M tablets (1500mcg/150mg) can cause drowsiness, blurred vision, and dizziness. Refrain from driving if experiencing these effects.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Iprag M 1500mcg/150mg sustained-release tablets. Dosage modification of Iprag M 1500mcg/150mg sustained-release tablets may be necessary. A physician's consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Iprag M 1500mcg/150mg sustained-release tablets in patients with liver impairment appears to present a low risk. Current evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Iprag M 1500mcg/150mg Tablet SR :
Should you forget to take your Iprag M 1500mcg/150mg SR Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Iprag M 1500mcg/150mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
